Related references
Note: Only part of the references are listed.The Health Impact of MAFLD, a Novel Disease Cluster of NAFLD, Is Amplified by the Integrated Effect of Fatty Liver Disease-Related Genetic Variants
Zhenqiu Liu et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)
Trends in the Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease in the United States
Robert J. Wong et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)
Associations Between Nonalcoholic Fatty Liver Disease and Cancers in a Large Cohort in China
Zhenyu Wang et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)
Epidemiology of Hepatocellular Carcinoma
Katherine A. McGlynn et al.
HEPATOLOGY (2021)
From NAFLD to MAFLD: Implications of a Premature Change in Terminology
Zobair M. Younossi et al.
HEPATOLOGY (2021)
Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals
Alessandro Mantovani et al.
GUT (2021)
Redefining fatty liver disease: an international patient perspective
Gamal Shiha et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2021)
On the Proposed Definition of Metabolic-Associated Fatty Liver Disease
Vincent Wai-Sun Wong et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)
Metabolic Dysfunction-Associated Fatty Liver Disease and Incident Cardiovascular Disease Risk: A Nationwide Cohort Study
Hokyou Lee et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)
Differential Clinical Characteristics and Mortality Outcomes in Persons With NAFLD and/or MAFLD
Vy H. Nguyen et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)
Impact of the New Definition of Metabolic Associated Fatty Liver Disease on the Epidemiology of the Disease
Vincent Wai-Sun Wong et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)
The sub-Saharan Africa position statement on the redefinition of fatty liver disease: From NAFLD to MAFLD
C. Wendy Spearman et al.
JOURNAL OF HEPATOLOGY (2021)
Capturing patient experience: A qualitative study of change from NAFLD to MAFLD real-time feedback
Shereen Abdel Alem et al.
JOURNAL OF HEPATOLOGY (2021)
The NAFLD-MAFLD debate: Eminence vs evidence
Yasser Fouad et al.
LIVER INTERNATIONAL (2021)
The Latin American Association for the Study of the Liver (ALEH) position statement on the redefinition of fatty liver disease
Nahum Mendez-Sanchez et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2021)
Nomenclature and definition of metabolic-associated fatty liver disease: a consensus from the Middle East and north Africa
Gamal Shiha et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2021)
Does the risk of cardiovascular events differ between biopsy-proven NAFLD and MAFLD?
Gabriel Tayguara Silveira Guerreiro et al.
HEPATOLOGY INTERNATIONAL (2021)
Change from NAFLD to MAFLD increases the awareness of fatty liver disease in primary care physicians and specialists
Yasser Fouad et al.
JOURNAL OF HEPATOLOGY (2021)
Prevalence of NAFLD, MAFLD and associated advanced fibrosis in the contemporary United States population
Stefano Ciardullo et al.
LIVER INTERNATIONAL (2021)
MAFLD and risk of CKD
Dan-Qin Sun et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2021)
Redefinition of fatty liver disease from NAFLD to MAFLD raised disease awareness: Mexican experience
Nahum Mendez-Sanchez et al.
JOURNAL OF HEPATOLOGY (2021)
Non-alcoholic fatty liver disease
Elizabeth E. Powell et al.
LANCET (2021)
A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis
Philip N. Newsome et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Cardiovascular and renal burdens of metabolic associated fatty liver disease from serial US national surveys, 1999-2016
Hao-Jie Zhang et al.
CHINESE MEDICAL JOURNAL (2021)
Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States
Donghee Kim et al.
JOURNAL OF HEPATOLOGY (2021)
Suboptimal treatment of dyslipidemia in patients with nonalcoholic fatty liver disease
Stanley Khoo et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2020)
Empagliflozin Effectively Lowers Liver Fat Content in Well-Controlled Type 2 Diabetes: A Randomized, Double-Blind, Phase 4, Placebo-Controlled Trial
Sabine Kahl et al.
DIABETES CARE (2020)
Effect of Metabolic Traits on the Risk of Cirrhosis and Hepatocellular Cancer in Nonalcoholic Fatty Liver Disease
Fasiha Kanwal et al.
HEPATOLOGY (2020)
Modelling NAFLD disease burden in four Asian regions-2019-2030
Chris Estes et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)
Serial Transient Elastography Examinations to Monitor Patients With Type 2 Diabetes: A Prospective Cohort Study
Hye Won Lee et al.
HEPATOLOGY (2020)
Complications, morbidity and mortality of nonalcoholic fatty liver disease
Alessandro Mantovani et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2020)
The association between nonalcoholic fatty liver disease and esophageal, stomach, or colorectal cancer: National population-based cohort study
Jung-Min Lee et al.
PLOS ONE (2020)
Positive Hepatitis B Core Antibody Is Associated With Cirrhosis and Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
Ting Ting Chan et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
Mohammed Eslam et al.
JOURNAL OF HEPATOLOGY (2020)
Prevalence and Risk Factors of Metabolic Associated Fatty Liver Disease in Xinxiang, China
Hongbin Li et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2020)
Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies
Helen Jarvis et al.
PLOS MEDICINE (2020)
Association between nonalcoholic fatty liver disease and extrahepatic cancers: a systematic review and meta-analysis
Shou-Sheng Liu et al.
LIPIDS IN HEALTH AND DISEASE (2020)
Comparison of MAFLD and NAFLD diagnostic criteria in real world
Su Lin et al.
LIVER INTERNATIONAL (2020)
The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
Mohammed Eslam et al.
HEPATOLOGY INTERNATIONAL (2020)
The times they are a-changin' (for NAFLD as well)
Vlad Ratziu et al.
JOURNAL OF HEPATOLOGY (2020)
Letter regarding A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
Lung-Yi Mak et al.
JOURNAL OF HEPATOLOGY (2020)
Nonalcoholic Fatty Liver Disease and the Heart JACC State-of-the-Art Review
Eric P. Stahl et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts
Myriam Alexander et al.
BMC MEDICINE (2019)
Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis
Jie Li et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2019)
The risk of incident extrahepatic cancers is higher in non-alcoholic fatty liver disease than obesity - A longitudinal cohort study
Alina M. Allen et al.
JOURNAL OF HEPATOLOGY (2019)
A global view of hepatocellular carcinoma: trends, risk, prevention and management
Ju Dong Yang et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Complete Resolution of Nonalcoholic Fatty Liver Disease After Bariatric Surgery: A Systematic Review and Meta-analysis
Yung Lee et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
A nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011-2015 update
Ryosuke Tateishi et al.
JOURNAL OF GASTROENTEROLOGY (2019)
Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017Part 1: Definition, risk factors and assessment
Vincent Wai-Sun Wong et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2018)
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Zobair Younossi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Epidemiology of diabetes and diabetic complications in China
Ronald C. W. Ma
DIABETOLOGIA (2018)
Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study
Eduardo Vilar-Gomez et al.
GASTROENTEROLOGY (2018)
Diabetes, Plasma Glucose, and Incidence of Fatty Liver, Cirrhosis, and Liver Cancer: A Prospective Study of 0.5 Million People
Yuanjie Pang et al.
HEPATOLOGY (2018)
Advanced liver fibrosis but not steatosis is independently associated with albuminuria in Chinese patients with type 2 diabetes
Ming-Wai Yeung et al.
JOURNAL OF HEPATOLOGY (2018)
Association between non-alcoholic fatty liver disease and cancer incidence rate
Gi-Ae Kim et al.
JOURNAL OF HEPATOLOGY (2018)
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030
Chris Estes et al.
JOURNAL OF HEPATOLOGY (2018)
Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease
Quentin M. Anstee et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Noninvasive biomarkers in NAFLD and NASH - current progress and future promise
Vincent Wai-Sun Wong et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease
Vincent Wai-Sun Wong et al.
JOURNAL OF HEPATOLOGY (2018)
Is nonalcoholic fatty liver disease associated with the development of prostate cancer? A nationwide study with 10,516,985 Korean men
Yoon Jin Choi et al.
PLOS ONE (2018)
Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease
Fasiha Kanwal et al.
GASTROENTEROLOGY (2018)
Non-alcoholic fatty liver diseases and risk of colorectal neoplasia
J. S. Ahn et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Concurrent fatty liver increases risk of hepatocellular carcinoma among patients with chronic hepatitis B
Anthony W. H. Chan et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2017)
Obesity
Pedro Gonzalez-Muniesa et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Long-Term Clinical Outcomes After Fatty Liver Screening in Patients Undergoing Coronary Angiogram: A Prospective Cohort Study
Vincent Wai-Sun Wong et al.
HEPATOLOGY (2016)
Trends in the Burden of Nonalcoholic Fatty Liver Disease in a United States Cohort of Veterans
Fasiha Kanwal et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Steven P. Marso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Pathogenesis and novel treatment options for non-alcoholic steatohepatitis
Vincent Wai-Sun Wong et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2016)
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
Paul Angulo et al.
GASTROENTEROLOGY (2015)
Incidence of non-alcoholic fatty liver disease in Hong Kong: A population study with paired proton-magnetic resonance spectroscopy
Vincent Wai-Sun Wong et al.
JOURNAL OF HEPATOLOGY (2015)
Tuberculosis and Hepatic Steatosis Are Prevalent Liver Pathology Findings among HIV-Infected Patients in South Africa
Christopher J. Hoffmann et al.
PLOS ONE (2015)
Prevalence of and predictive factors for nonalcoholic fatty liver disease in Sudanese individuals with type 2 diabetes: Is metabolic syndrome the culprit?
Ahmed O. Almobarak et al.
ARAB JOURNAL OF GASTROENTEROLOGY (2015)
Risk factors for perihilar cholangiocarcinoma: A hospital-based case-control study
Ban Seok Lee et al.
LIVER INTERNATIONAL (2015)
Hepatitis B and C in African Americans: Current Status and Continued Challenges
Kimberly A. Forde et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
Hepatocellular cancer: The impact of obesity, type 2 diabetes and a multidisciplinary team
Jessica Dyson et al.
JOURNAL OF HEPATOLOGY (2014)
NAFLD prevalence differs among hispanic subgroups: The multi-ethnic study of atherosclerosis
Michael Wayne Fleischman et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Association of Non-alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-analysis
Giovanni Musso et al.
PLOS MEDICINE (2014)
Non alcoholic fatty liver disease (NAFLD) in a Sudanese population: What is the prevalence and risk factors?
Ahmed O. Almobarak et al.
ARAB JOURNAL OF GASTROENTEROLOGY (2014)
The prevalence of nonalcoholic fatty liver disease in the Americas
Jorge A. Lopez-Velazquez et al.
ANNALS OF HEPATOLOGY (2014)
Prevalence and risk factors of non-alcoholic fatty liver disease in a multiracial suburban Asian population in Malaysia
Seok-Chin Goh et al.
HEPATOLOGY INTERNATIONAL (2013)
Medical Risk Factors Associated with Cholangiocarcinoma in Taiwan: A Population-Based Case-Control Study
Jeffrey S. Chang et al.
PLOS ONE (2013)
International Variation in Prostate Cancer Incidence and Mortality Rates
Melissa M. Center et al.
EUROPEAN UROLOGY (2012)
Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort
Matthew J. Armstrong et al.
JOURNAL OF HEPATOLOGY (2012)
Hepatitis B virus infection and fatty liver in the general population
Vincent Wai-Sun Wong et al.
JOURNAL OF HEPATOLOGY (2012)
Heritability of non-alcoholic fatty liver disease and association with abnormal vascular parameters: A twin study
Adam D. Tarnoki et al.
LIVER INTERNATIONAL (2012)
High prevalence of colorectal neoplasm in patients with non-alcoholic steatohepatitis
Vincent Wai-Sun Wong et al.
GUT (2011)
Prevalence and factors associated with the presence of nonalcoholic fatty liver disease in an adult population in Spain
Llorenc Caballeria et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2010)
Nonobese Population in a Developing Country Has a High Prevalence of Nonalcoholic Fatty Liver and Significant Liver Disease
Kausik Das et al.
HEPATOLOGY (2010)
Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis
Vasilios G. Athyros et al.
LANCET (2010)
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
Giovanni Targher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Non-alcoholic fatty liver disease (NAFLD) in the Western Cape: A descriptive analysis
F. C. Kruger et al.
SAMJ SOUTH AFRICAN MEDICAL JOURNAL (2010)
The Histologic Spectrum of Liver Disease in African-American, Non-Hispanic White, and Hispanic Obesity Surgery Patients
Eric R. Kallwitz et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Ultrasonographic Hepatic Steatosis Increases Prediction of Mortality Risk From Elevated Serum Gamma-Glutamyl Transpeptidase Levels
Robin Haring et al.
HEPATOLOGY (2009)
Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005
Sean F. Altekruse et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Prevalence and risk factors for non-alcoholic fatty liver disease among adults in an urban Sri Lankan population
Anuradha S. Dassanayake et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)
Non-alcoholic fatty liver disease and its association with obesity, insulin resistance and increased serum levels of C-reactive protein in Hispanics
Arnoldo Riquelme et al.
LIVER INTERNATIONAL (2009)
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Stefano Romeo et al.
NATURE GENETICS (2008)
Incidence and natural course of fatty liver in the general population: the dionysos study
Giorgio Bedogni et al.
HEPATOLOGY (2007)
Non-alcoholic fatty liver disease and metabolic syndrome in Brazilian middle-aged and older adults
Mauro Karnikowski et al.
SAO PAULO MEDICAL JOURNAL (2007)
Risk factors for intrahepatic and extrahepatic Cholangiocarcinoma in the United States: A population-based case-control study
Tania M. Welzelt et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Prevalence of non-alcoholic fatty liver disease: population based study
Deepak Amarapurkar et al.
ANNALS OF HEPATOLOGY (2007)
Diagnostic and predictive factors of significant liver fibrosis and minimal lesions in patients with persistent unexplained elevated transaminases. A prospective multicenter study
Victor de Ledinghen et al.
JOURNAL OF HEPATOLOGY (2006)
Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of Taiwan: Metabolic significance of nonalcoholic fatty liver disease in nonobese adults
Chien-Hua Chen et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2006)
The metabolic syndrome as a predictor of nonalcoholic fatty liver disease
M Hamaguchi et al.
ANNALS OF INTERNAL MEDICINE (2005)
Prevalence of and risk factors for fatty liver in a general population of Shanghai, China
JG Fan et al.
JOURNAL OF HEPATOLOGY (2005)
Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos Nutrition and Liver Study
G Bedogni et al.
HEPATOLOGY (2005)
Chronological development of elevated aminotransferases in a nonalcoholic population
A Suzuki et al.
HEPATOLOGY (2005)
Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity
JD Browning et al.
HEPATOLOGY (2004)
Share Paper
